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Abstract
Background: The generation of long-lived memory T cells is critical for successful vaccination but the factors controlling
their differentiation are still poorly defined. We tested the hypothesis that the strength of T cell receptor (TCR) signaling
contributed to memory CD8
+ T cell generation.
Methodology/Principal Findings: We manipulated the density of antigenic epitope presented by dendritic cells to mouse
naı ¨ve CD8
+ T cells, without varying TCR affinity. Our results show that a two-fold decrease in antigen dose selectively affects
memory CD8
+ T cell generation without influencing T cell expansion and acquisition of effector functions. Moreover, we
show that low antigen dose alters the duration of the interaction between T cells and dendritic cells and finely tunes the
expression level of the transcription factors Eomes and Bcl6. Furthermore, we demonstrate that priming with higher epitope
density results in a 2-fold decrease in the expression of Neuron-derived orphan nuclear receptor 1 (Nor-1) and this correlates
with a lower level of conversion of Bcl-2 into a pro-apoptotic molecule and an increased number of memory T cells.
Conclusions: Our results show that the amount of antigen encountered by naı ¨ve CD8
+ T cells following immunization with
dendritic cells does not influence the generation of functional effector CD8
+ T cells but rather the number of CD8
+ memory
T cells that persist in the host. Our data support a model where antigenic epitope density sensed by CD8
+ T cells at priming
influences memory generation by modulating Bcl6, Eomes and Nor-1 expression.
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Introduction
During an immune response, antigen (Ag)-specific naı ¨ve T cells
undergo massive proliferation and differentiate into effectors that
eliminate the pathogen. After Ag clearance, 90–95% of effector T
cells die while a few differentiate into long-lived memory T (Tm)
cells. The efficient protection provided by Tm cells is due to both
the increased number of Ag-specific T cells as well as their
enhanced sensitivity upon Ag re-exposure [1]. Therefore, Tm cell
development is critical for the control of recurrent infections and
for the success of vaccination. A better understanding of the
molecular events leading to Tm cell generation is crucial to
improve vaccination. However, there is limited information
regarding the signals that dictate Tm cell generation and we still
do not known if the strength of T cell receptor (TCR) signaling
and the affinity/avidity of the TCR contribute to the development
of CD8
+ Tm cells.
While strong experimental evidences exist for a role of the
strength of TCR engagement for CD4
+ Tm cell generation [2,3,4]
such evidences are scarce or against this concept in the
development of CD8
+ Tm cells [5,6]. A recent study has evaluated
the role of TCR affinity for the generation of effector and memory
CD8
+ T cells [6]. Using altered peptide ligands, they have shown
that Ags with very low affinity for the TCR are able to induce the
complete differentiation of naı ¨ve CD8
+ T cells into effector and
memory cells. However, the strength of TCR-ligand interaction
affected the level of T cell expansion [6]. To evaluate the
contribution of the strength of TCR signaling in the generation of
effector and memory CD8
+ T cells, rather than modifying the
nature of Ag, we decided to manipulate the level of Ag
presentation by dendritic cells (DCs) to naı ¨ve CD8
+ T cells while
maintaining constant the affinity of the TCR for its ligand.
Unexpectedly, we observed that lowering the avidity of the TCR-
MHC-peptide interactions by decreasing Ag dose by only two-fold
strongly affected the generation of CD8
+ Tm cells without
impacting effector generation. Moreover, we showed that lower
density of MHC-peptide complexes at the surface of DCs alters the
quality of T-DC interaction. Consequently, the induction of the
molecular program required for CD8
+ Tm cell development is
altered as shown by a fine tuning in expression level of the
transcription factors Eomes and Bcl6. Furthermore, our results
showed that higher level of TCR engagement at priming is
necessary to promote the survival of memory precursor CD8
+ T
cells during the contraction phase of the response. Indeed, we
identified Neuron-derived orphan nuclear receptor 1 (Nor-1) as a
possible new pathway controlling Ag-specific CD8
+ T cell survival
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the avidity of the TCR for its ligand influences CD8
+ Tm cell
generation.
Results
Epitope density influences CD8
+ T cell fate
To study the role of TCR signaling strength for CD8
+ Tm cell
development, we chose to only vary the dose of Ag while keeping
TCR affinity and inflammation constant. To eliminate any
influence of TCR affinity, we adoptively transferred ovalbumin
(OVA)-specific CD8
+ T cells bearing a monoclonal TCR specific
for the K
b-SIINFEKL complex. To maintain constant and low
levels of inflammation, we immunized these mice with DCs while
we manipulated Ag dose by loading the DCs with different
densities of major histocompatibility (MHC)-peptide complexes.
Furthermore, DC immunization favors the early generation of Ag-
specific CD8
+ T cells with a memory precursor phenotype [7,8,9].
Although these cells have a memory precursor phenotype at the
peak of the response, they also acquire effector functions and go
through a normal contraction phase [7,9]. This suggests that they
must undergo further maturation to become long-lived CD8
+ Tm
cells and that only a fraction of the memory precursors has
acquired the proper genetic program to become long-lived Tm
cells. Therefore, this system allows us to evaluate if the strength of
TCR signaling at priming impinges on the optimal differentiation
of memory CD8
+ precursors into long-lived Tm cells.
To generate DCs loaded with different densities of MHC-
peptide complexes, bone marrow derived mature DCs were pulsed
overnight (DC O/N) or 3 h (DC 3 h) with the SIINFEKL peptide.
Very importantly, the DCs were kept in culture and were activated
with LPS for the same amount of time to obtain DCs with similar
phenotype except for Ag density. DC O/N express two-fold more
K
b-SIINFEKL complexes than DC 3 h (Figure 1A) as measured
using the 25.D1.16 mAb that specifically recognizes this peptide-
MHC complex [10]. Importantly, the two types of DCs express
similar level of MHC class I and II molecules, as well as CD86 and
produce similar amount of interleukin (IL)-12 (Figure S1). Thus,
the only difference between DC O/N and DC 3 h is the amount
of K
b-SIINFEKL they express. These DCs were used to immunize
recipient mice (CD45.1
+) which have been adoptively transferred
with OT-I or Vb5LTAOCa
2/2 T cells (CD45.2
+) expressing a
TCR specific for K
b-SIINFEKL [11,12]. We always transfer
female T cells into female mice followed by immunization with
male DCs to provide the T cell help necessary to generate
functional CD8
+ Tm cells [1]. Four days after immunization, a
superficial lymph node (LN) was removed by surgery to evaluate
the number of Ag-specific CD8
+ T cells generated. As shown in
Figure 1B and Figure S2, the amount of peptide-MHC complexes
expressed by DCs did not influence the expansion phase of OVA-
specific T cells. Moreover, similar number of effectors was
generated in the spleen (Figure 1C) and tertiary sites (Figure
S3A). In contrast, the level of Ag presentation to naı ¨ve CD8
+ T
cells impacted Tm cell differentiation (Figure 1B and D). OVA-
Figure 1. Epitope density influences CD8
+ Tm generation. A. The duration of peptide loading on DCs affects MHC-peptide expression.
Representative histogram of K
b-SIINFEKL expression by DCs loaded 3 h (DC 3 h) or O/N (DC O/N) with SIINFEKL (left); dashed line, DCs pulsed with an
irrelevant peptide (DC IRR). The mean fluorescence intensity (MFI) of K
b-SIINFEKL expression is indicated on the top of the respective histogram. Right
panel, compilation of the MFI of K
b-SIINFEKL expression for DC O/N versus DC 3 h. Results are from 13 independent experiments. B. The number of
effector (day 4) and memory (day 45) OVA-specific T cells recovered from LNs after immunization with DC O/N or DC 3 h is shown. Number of Ag-
specific T cells was normalized to one million cells to correct for LN size variation. Each dot represents a mouse. Mice in which no Tm cells were
generated were not included. C. The number of OVA-specific effectors recovered from the spleen (day 4) after immunization with DC O/N or DC 3 h is
shown. Each dot represents a mouse. D. The percentage of mice with Tm cells is shown. Statistical analysis was done using a Student’s t test.
doi:10.1371/journal.pone.0013740.g001
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+ Tm cells were not generated in all mice that were
immunized with DC 3 h (6/16) while they were almost always
generated in mice immunized with DC O/N (16/19; Figure 1D).
Moreover, immunization with DC 3 h generated seven times
fewer CD8
+ Tm cells in the LNs (Figure 1B and Figure S2) and
four times less in tertiary sites (Figure S3B). The number of CD8
+
Tm cells generated was also reduced in the spleen (Figure S3C).
Furthermore, with both Ag doses, Tm cells had a central memory
phenotype (Figure S4A). In addition, immunization with DCs
loaded with an irrelevant peptide did not induce OVA-specific
CD8
+ T cell response (Figure S2). These results show that a
stronger TCR signal is necessary for the efficient development of
CD8
+ Tm cells but not for the expansion of Ag-specific CD8
+ T
cells.
TCR engagement level does not alter CD8
+ T cell
response kinetic
The size of the Tm cell pool generated after Ag encounter is
usually directly proportional to the extent of T cell expansion [13].
Thus, it is possible that immunization with high Ag dose prolongs
T cell expansion which will generate more Ag-specific T cells
leading to the generation of more CD8
+ Tm cells. However, we
observed a similar kinetic of expansion where the peak of the
response is at day 4 for both types of immunization (Figure 2A).
Moreover, the contraction phase is initiated at the same time in
the two OVA-specific populations but is more pronounced with
DC 3 h (Figure 2A). Very importantly, similar results were
obtained with a low frequency (10
4) of naı ¨ve T cell precursors
(Figure 2B and Figure S5) indicating that the use of a high
frequency of naı ¨ve precursors did not limit the expansion of T cells
after immunization with DCs presenting a higher density of
epitope. These results suggest that epitope density on DCs or
TCR-ligand avidity does not regulate Ag specific CD8
+ T cell
proliferation after priming but influences their survival during
contraction.
Phenotype and functions are not influenced by the
amount of Ag encountered by naı ¨ve CD8
+ T cells
The inefficient CD8
+ Tm cell development after immunization
with DCs presenting low Ag density could result from an altered
phenotype of Ag-specific T cells at the peak of the response.
However, we did not observed any differences in the expression of
cell surface (Ly6C, Sca-1 and 4-1BB), activation (CD44, 1B11 and
CD5) and migratory (CD62L and CCR7) markers, as well as
cytokine receptors (CD25, CD122 and CD127) (Figure S4). In
both instances, the effectors generated did not acquired KLRG-1
expression (not shown) and maintained high level of CD127
(Figure S4). This suggests that the reduced production of CD8
+
Tm cells after immunization with DC 3 h is not due to the
acquisition of a short-lived effector phenotype by Ag-specific CD8
+
T cells at the peak of the response. Furthermore, effector functions
were not affected by epitope density (Figure S6). These results
suggest that the 10-fold reduction in CD8
+ Tm cell generation
with low level of Ag presentation is not due to the improper
differentiation of naı ¨ve CD8
+ T cells into effectors.
Epitope density dictates the quality of T-DC interaction
The variation in the level of Ag presented to naı ¨ve T cells could
influence the time of interaction between naı ¨ve T cells and DCs, a
key parameter for the induction of T cell response [14,15,16].
Furthermore, it was shown that a reduction in the interaction time
between DCs and naı ¨ve CD8
+ T cells due to ICAM-1 deficiency
resulted in poor CD8
+ Tm cell generation [16]. Therefore, we
have measured by time-lapse microscopy the duration of contact
between naı ¨ve CD8
+ T cells and DC O/N or DC 3 h. The
interaction time between naı ¨ve OVA-specific CD8
+ T cells and
DCs tends to be lower with DC 3 h (Figure 3A). Importantly, the
percentage of naı ¨ve CD8
+ T cells interacting for more than 640
seconds is higher with DCs loaded O/N with the antigenic peptide
(Figure 3B). Long-lasting T-DC interaction leads to an intimate
contact (engulfment) between T cells and DCs and is a key event
controlling T cell activation [14], we evaluated the impact of the
Ag dose on the frequency of T-DC interaction leading to
engulfment. The frequency of T cell engulfment by DCs was
proportional to the level of Ag presented by DCs to naı ¨ve CD8
+ T
cells (50% for DC O/N versus 30% for DC 3 h; Figure 3C). Thus,
we conclude that a higher density of Ag presented by DCs
promotes a long-lasting T-DC interaction at priming which results
in efficient generation of long-lived CD8
+ Tm cells. Therefore, we
propose that engulfment of T cells by DCs is essential to generate
an optimal TCR signal that will promote CD8
+ Tm cell
generation.
Figure 2. Epitope density does not prolong CD8
+ T cell
expansion. A. The number of CD8
+CD45.2
+ T cells was quantified
over time after immunization with DC O/N and DC 3 h. LNs were
sequentially removed to follow T cell response. The number of
CD8
+CD45.2
+ T cells was normalized to one million cells to correct for
LN size variation (relative number). * p,0.05. Results are pooled from 2
independent experiments with 3 mice per group. B. Generation of CD8
+
Tm cells is also affected by epitope density when naı ¨ve T cell precursor
frequency is low. 10
4 OT-I T cells were adoptively transferred. The
relative number of Ag-specific T cells recovered over time from the LNs
is shown. Results from one representative experiment out of two are
shown with 3 mice per group. Statistical analysis was done using a
Student’s t test.
doi:10.1371/journal.pone.0013740.g002
Antigen Dose and Memory
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a specific genetic program controlling CD8
+ Tm cell
generation
Our model puts us in a unique position to decipher the genetic
program required for CD8
+ Tm cell development since manip-
ulating epitope density specifically affects CD8
+ Tm cell
generation. Furthermore, our model also offers the advantage
that inflammation level remains constant even when we increase
Ag dose. Therefore, we evaluated the expression level of key
transcription factors involved in CD8
+ T cell response. The
transcription factor T-bet is necessary for the generation of CD8
+
Tm cells [17] and its expression level dictate the fate of effector
CD8
+ T cells [8]. Indeed, high T-bet level is associated with the
generation of short-lived effectors while low level of T-bet is
present in CD8
+ memory precursors [8]. Therefore, it was possible
that a certain level of TCR engagement was necessary to up-
regulate T-bet expression. However, at the peak of the response
(day 4), T-bet expression was similar in sorted OVA-specific CD8
+
T cells generated with low and high Ag doses (Figure 4A and B).
In contrast, high level of Eomes expression correlates with
CD8
+ Tm cell development but direct evidence for a role of
Eomes is still lacking [18]. At the peak of the response, we
observed a two-fold increase in Eomes expression by effectors
generated following immunization with DC O/N when compared
to DC 3 h (Figure 4B). This suggests that the strength of TCR
signaling directly regulate Eomes expression.
The transcriptional repressor Bcl6 regulates B and T cell
memory generation [19,20,21,22] but unlike T-bet and Eomes,
Bcl6 is not necessary for effector generation [21,22]. Accordingly,
we observed a 1.3–1.6-fold increase in Bcl6 expression in primed
Ag-specific CD8
+ T cells that efficiently become Tm cells when
compared to those that do not (Figure 4B). This suggests that a
Figure 3. Epitope density dictates the duration and the quality
of T-DC interaction. A. The duration of contact between naı ¨ve CD8
+ T
cells and DC O/N or DC 3 h was measured in vitro using time-lapse
microscopy. B. The percentage of naı ¨ve CD8
+ T cells interacting for
more then 640 seconds with DCs is shown for DC 3 h or DC O/N. C. The
proportion of T-DC interaction that leads to engulfment of naı ¨ve CD8
+ T
cells by DCs is shown for DC O/N or DC 3 h. Statistical analysis was done
using a Mann-Whitney test.
doi:10.1371/journal.pone.0013740.g003
Figure 4. The amount of Ag encountered by naı ¨ve CD8
+ T cells
influences transcription factor expression. A. No effect of Ag dose
on T-bet expression. The left panel shows intracellular staining for T-bet
in effectors at day 4 post-immunization with DC O/N or DC 3 h. The
recipient endogenous population was used as a control. The right panel
shows compilation of T-bet MFI. B. TCR engagement level finely tunes
expression of key transcription factors. At d4 post-immunization, OVA-
specific T cells (CD8
+CD45.2
+) were sorted from spleen and LNs to
perform qPCR analysis. The relative expression of mRNA in effector
CD8
+ T cells obtained after immunization with DC O/N or DC 3 h is
shown (normalized to HPRT). 3 independent experiments with 3 mice
per group. Statistical analysis was done using a Mann-Whitney test.
doi:10.1371/journal.pone.0013740.g004
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CD8
+ Tm cells and that the level of TCR engagement controls
Bcl6 expression level.
Therefore, we conclude that epitope density at priming
influences the genetic signature of Ag-specific T cells which then
impinges on their further differentiation into CD8
+ Tm cells.
Similar expression of pro- and anti-apoptotic molecules
in CD8+ effectors generated with low and high density of
Ag
One possible explanation for inefficient Tm cell generation after
immunization with DCs presenting Ag at low density could be an
increase death rate of Ag-specific effectors. Apoptosis can be
induced in effector CD8
+ T cells by different molecules such as
Spi2A, Fas ligand (FasL) and Bim while survival can be promoted
by the anti-apoptotic molecules Bcl-2 and Bcl-xL. Bcl-2 expression
in OVA-specific T cells was not dependent on the amount of TCR
engaged with MHC-peptide complexes (Figure S7). Moreover,
there was no significant difference in the relative expression of
Spi2A, FasL, Bim and Bcl-XL in OVA-specific T cells generated
after immunization with DC 3 h or DC O/N (Figure S7). These
results show that the severe reduction in CD8
+ Tm cell generation
in our model is not a consequence of inappropriate expression of
these pro- and anti-apoptotic molecules.
Nor-1/Bcl2, a novel pathway controlling effector CD8
+ T
cell fate
Recently, Bevan’s group reported that low avidity effector CD4
+
T cells unable to differentiate into CD4
+ Tm cells have up-
regulated Bim and Nor-1 expression [4]. Nor-1 is a member of the
nuclear receptor family of intracellular transcription factor
encoded by the Nr4a3 gene [23]. In the thymus, Nor-1 is
associated with apoptosis and negative selection [24]. Further-
more, Nor-1 translocates to the mitochondria after TCR-mediated
stimulation in thymocytes [25] where its binding to Bcl-2 exposes
the Bcl-2 BH3 domain. This converts Bcl-2 into a pro-apoptotic
molecule (thereafter named Bcl-2-BH3) [25]. Then, Bcl-2-BH3
contributes to cytochrome c release leading to apoptosis. The
possible role of Nor-1 in T cell apoptosis led us to evaluate its
expression level in primed Ag-specific CD8
+ T cells that are able
or not to generate Tm cells. The relative expression of the Nr4A3
gene was two-fold less in OVA-specific CD8
+ T cells generated
after immunization with DC O/N compared to DC 3 h
(Figure 5A). Since Nor-1 activates apoptosis via binding to Bcl-2
and exposition of the BH3 domain of Bcl-2, we evaluated if the
higher level of Nor-1 expression promoted the conversion of Bcl-2
into a pro-apoptotic molecule. Using a mAb that recognizes
specifically the Bcl-2-BH3 pro-apoptotic form of Bcl-2 [25], we
showed that the expression of Bcl-2-BH3 was increased in effectors
obtained after immunization with DCs presenting low versus high
level of Ag at d4 and d7 post-immunization (Figure 5B–D).
These results show that the level of TCR engagement regulates
the expression of Nor-1 which can, via its association with Bcl-2,
promote Ag-specific CD8
+ T cell death. Furthermore, this is the
first suggestion that Nor-1 regulates effector CD8
+ T cell fate.
Discussion
Our results show that the amount of Ag encountered by naı ¨ve
CD8
+ T cells following DC immunization does not influence the
generation of functional effector CD8
+ T cells but rather affects
CD8
+ Tm cell differentiation. In the past, few groups have studied
the impact of Ag dose on CD8
+ Tm cell development. These
studies evaluated CD8
+ T cell response to infection and reported
that variation in Ag level selectively affects the number of effectors
generated without influencing memory differentiation [5,26]. The
fact that we did not see any effect of Ag dose on the expansion of
Ag-specific CD8
+ T cells could be because we varied by only two-
fold the amount of MHC-peptide complexes presented to naı ¨ve
CD8
+ T cells. Additionally, the level of inflammation may also
account for this difference, where DC immunization induces very
low level of inflammation relative to the inflammation induced
upon infection. Furthermore, in our experiment, we studied the
response of monoclonal, rather than polyclonal, T cells bearing the
same TCR and therefore allowing us to evaluate the impact of Ag
dose on CD8
+ T cell response while maintaining TCR affinity
constant. In a polyclonal repertoire, an increase in Ag concentra-
tion may induce a stronger CD8
+ T cell response by recruiting T
cells with lower affinity for Ag, thereby yielding a different
interpretation of the results. In our model, epitope density
selectively affected CD8
+ Tm cell generation. Possible explana-
tions for this difference are increased inflammation and more
sustained antigenic presentation during infection. Yet, it is possible
Figure 5. Selective downregulation of Nor-1 expression in
effector CD8
+ T cells generated with high Ag dose. A. Expression
of Nor-1 in effector CD8
+ T cells. Effectors (CD8
+CD45.2
+) were sorted
from spleen and LNs at d4 post-immunization to perform qPCR. The
relative expression of Nor-1 after immunization with DC O/N or DC 3 h
is shown (normalized to HPRT). 3 independent experiments with 3 mice
per group. B. Epitope density influences the exposure of the BH3
domain of Bcl-2 in CD8
+ effector T cells. The overlays show staining
gated on OVA-specific effector (CD8
+CD45.2
+) T cells obtained at day 4
post-immunization with DC O/N or DC 3 h. The controls were isotype
and staining of the endogenous population (CD8
+CD45.2
2). C and D.
The histogram represents the percentage (C) and the MFI (D) of Bcl-2-
BH3 expression by Ag-specific T cells at d4 or d7 post-immunization
with DC O/N or DC 3 h. 3 independent experiments with 2–3 mice per
group. Statistical analysis was done using a Mann-Whitney test for
panel A and a Student’s t test for panels C and D.
doi:10.1371/journal.pone.0013740.g005
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+ Tm cell generation are different
when the level of inflammation is high. Furthermore, this is an
agreement with the study of Joshi et al. [8] who have shown that
the level of inflammation dictates the fate of effectors into short-
lived cells or memory precursors. Indeed, effector CD8
+ T cells
obtained with our immunization protocol have a memory
precursor phenotype (CD62L
hi, IL-7R
hi and KLRG-1
lo) and that
they have also very good effector functions such as killing and
cytokine production. Moreover, even though immunization with
DCs expressing low or high level of the Ag leads both to the
generation of CD8
+ T cells with a memory precursor phenotype, it
is intriguing that the efficiency of CD8
+ Tm cell generation is
different between the two immunized groups. Therefore, a
different threshold of TCR engagement/signaling is required for
the generation of short-lived effectors and long-lived CD8
+ Tm
cells.
More recently, Zehn et al. have shown using altered peptide
ligands that very low affinity ligand are able to induce the full
differentiation program of naı ¨ve CD8
+ T cells leading to the
generation of effector and memory T cells [6]. However,
reduction of TCR ligand affinity impacted clonal burst-size [6].
Therefore, these experiments suggest that the strength of TCR
signaling only influences the expansion phase of the T cell
response without affecting CD8
+ Tm cell development. Our
results contrast with these data since we showed that a two-fold
reduction in the amount of Ag presented to naı ¨ve CD8
+ T cells,
which also decreased TCR signal strength and TCR avidity, had
a strong impact on CD8
+ Tm cell differentiation. We would like
to propose that naı ¨ve CD8
+ T cells respond differently to a
change in avidity resulting from a modification of TCR affinity
for its ligand versus a change in avidity that occurs due to a
variation of epitope density. Therefore, we would like to suggest
that decreasing affinity will blunt T cell expansion while reducing
epitope density will decrease CD8
+ Tm cell generation. In a
recent study, we have shown that lowering TCR expression level
on naı ¨ve T cells influences T cell expansion and not memory
generation [27]. However, to influence T cell expansion, the
number of TCRs need to be reduced to a very low level (,1000
molecules) [27]. With such a low level of TCR expression, it is
more than likely that T cell expansion is reduced due to a
decrease in T cell sensitivity that results from a loss of interaction
with self-ligands known to be necessary to promote T cell
responsiveness to foreign Ag [28,29,30,31,32,33]. Thus, we
would like to suggest that TCR density or affinity is involved in
T cell expansion while epitope density influences memory
generation.
Furthermore, it was shown by the group of Palmer that different
TCR signals are required for the generation of effector versus
memory CD8
+ T cells [34] which is consistent with our results
where a change in avidity, without a modification of affinity, only
affected CD8
+ Tm cell development. Thus, it is possible that a
change in the avidity of the interaction will lead to a more optimal
TCR signals allowing for the generation of CD8
+ Tm cells. In
support of that is our demonstration that reduction of the number
of MHC-peptide complexes presented by DCs to naı ¨ve CD8
+ T
cells decreases both the duration of T-DC contact and the number
of productive interaction as measured by the rate of T cell
engulfment by DCs. Also, the level of the co-receptor CD8
engaged could also explain how a modification of avidity by
manipulating Ag density affects memory generation while a
change in avidity by varying affinity impinges on expansion. It is
plausible that a change of TCR affinity will not influence the
extent of CD8 engagement with MHC class I molecules while a
variation of epitope density will.
The fact that our experimental system selectively affects the
development of CD8
+ Tm cells without influencing the number
and function of effectors generated have allowed us to identify key
molecular events required for CD8
+ Tm cell generation. We have
concentrated our effort on transcription factors known to control
T cell differentiation such as T-bet, Eomes and Bcl6. Our results
showed that the level of TCR engagement at priming selectively
influences the expression of Eomes and Bcl6. This suggests that
proper regulation of the expression of these two transcription
factors is critical to induce CD8
+ Tm cell differentiation. Although
the variation of Eomes expression is only two-fold, we believe that
this is enough to impact on CD8
+ Tm cell differentiation since it
was shown that the loss of one functional allele of Eomes is
sufficient to reduce the size of the CD8
+ Tm cell pool [17].
Moreover, small variations in the expression of a transcription
factor will probably have a strong impact by affecting the
transcription of multiple target genes. Furthermore, our results
suggest that Eomes expression is not only controlled by
inflammation level [18] and that the strength of TCR signaling
also influences its expression. However, we cannot exclude that the
longer duration of T-DC interaction might allow the DCs to
provide a signal that will in turn up-regulate Eomes expression. As
reported by Joshi et al. the level of TCR engagement by naı ¨ve
CD8
+ T cells did not influence the expression level of T-bet [8].
Furthermore, effectors unable to further differentiate into CD8
+
Tm cells express slightly lower level of Bcl6 than the one that will
generate memory. Since Bcl6 is essential for Tm cell development
[20,21], our results suggests that the strength of TCR signaling will
influence Bcl6 expression and that the lack of memory generation
with low dose of Ag could result from insufficient induction of Bcl6
expression. Since Bcl6 is not the mostly affected gene, our results
suggest that induction of Bcl6 alone is not sufficient to promote
CD8
+ Tm cell differentiation without the cooperation of other
transcription factors such as Eomes. In summary, the dose of Ag
critically affects the generation of CD8
+ Tm cells possibly by
modulating the expression of Eomes and Bcl6 at the peak of the
response. Although the number of CD8
+ Tm cells was reduced
more than seven-fold, the impact on transcription factor
expression was less important suggesting that small variation in
their expression is dramatic for the generation of CD8
+ Tm cells.
Such strong effects have also been reported in other biological
systems where mice express only one functional allele of Eomes
[17] and Bcl6 [35].
One effect of the strength of TCR signaling or of longer T-DC
interaction on CD8
+ Tm cell development is to control Nor-1
expression level to allow for a better survival of Ag-specific T cells
during contraction. Reducing the density of Ag presented to naı ¨ve
CD8
+ T cells led to a higher level of Nor-1 expression.
Furthermore, the 2-fold increase in Nor-1 expression correlates
with a 1.6-fold increase in Bcl2-BH3 staining and is consistent with
previous studies showing that Nor-1 can translocate to the
mitochondria to convert Bcl-2 into a pro-apoptotic molecules
[25].These results suggest that down-regulation of Nor-1 expres-
sion in effectors or memory precursors is essential to promote
survival during differentiation into CD8
+ Tm cells. Furthermore,
our results indicate that caution should be taken when interpreting
Bcl-2 expression level in activated T cells since Bcl-2 can also exist
in an apoptotic form when Nor-1 is present. We would also like to
propose that Nor-1 will play a similar role during CD4
+ Tm
differentiation. The group of Bevan has shown that Nor-1 and
Bim are highly overexpressed in effectors in which memory
differentiation is blunted [4], and we would like to suggest that
Nor-1 will inhibit CD4
+ Tm cell differentiation by inducing
apoptosis of Ag-specific CD4
+ T cells. Interestingly, we did not
Antigen Dose and Memory
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suggest that the strength of TCR signaling does not influence
survival of CD8
+ effectors or memory precursors by regulating
Bim expression but rather by controlling Nor-1 expression level.
Although our results suggest that Nor-1 influences the survival of
effectors by exposing the Bcl-2 BH3 loop, we cannot exclude that
Nor-1 interferes with the survival/differentiation of effectors into
CD8
+ Tm cells at the transcriptional level since Nor-1 is also a
transcription factor [23].
In summary, our data support a model where the epitope
density sensed by the CD8
+ T cell controls memory generation.
Therefore, one important impact of our work relates to anti-tumor
vaccination which relies on the use of DCs to immunize patients
against tumor Ags. The dose of Ag presented by the DCs should
be carefully analyzed to ensure proper differentiation of CD8
+ Tm
cells. Furthermore, analysis of the efficacy of the vaccination
strategy should not only be performed at the effector stage of the
response since the presence of effectors CD8
+ T cells does not
guarantee the proper generation of CD8
+ Tm cells.
Materials and Methods
Mice
C57BL/6, B6.SJL, OT-1 and Vb5LTAOCa
2/2 mice were
bred and maintained under specific pathogen-free condition. OT-
1 were on a RAG-deficient background while Vb5LTAOCa
2/2
were bred to Ca-deficient mice. OT-1 and Vb5LTAOCa
2/2
express the same TCR specific for the OVA257–264 (SIINKEKL)
peptide in the context of K
b [11,12]. Mouse experiments were
approved by the Animal Care Committee of the Maisonneuve-
Rosemont Hospital Research Center (protocols 2009-02, 2009-21
and 2007-09) and mice were treated according to the guidelines of
the Canadian Council on Animal Care.
Antibodies (Abs) and cytometry
Anti-CD8, -KLRG1, -Ly6C, -CD122 and rat anti-mouse IgG1
Abs were purchased from BD Bioscience. Anti-perforin, -
granzyme B, -CD127 Abs were from eBioscience. Anti-IL-2, -
TNFa, -CD45.2, -4-1BB, -CD43, -CD5, -CD44, -CD62L and -
CCR7 Abs were purchased from Biolegend Laboratories. Anti-
IFNc, -Sca-1, and -CD25 Abs were from Caltag Laboratories.
Anti -Bcl-2-BH3 Ab was purchased from Abgent and anti-T-bet
Ab from Santa Cruz Biotechnology. Fluorescently labeled
streptavidins were purchased from BD Bioscience. Staining and
analysis were done as described previously [9]. For Bcl-2 BH3
staining, cells were stained using the cytofix/cytoperm kit (BD
Bioscience) [25].
Preparation of peptide-pulsed DCs
DCs were generated as described previously [9]. To induce DC
maturation, 1 mg/ml lipopolysaccharide (LPS) (Sigma-Aldrich)
was added on day 6. The cells were either pulsed with OVA
peptide (SIINFEKL; 2 mg/ml) at day 6 overnight (DC O/N) or for
3 h (DC 3 h) at day 7 to keep both DC subsets for the same
amount of time in culture. The level of peptide-MHC complex
was evaluated before immunization using the 25.D1.16 Ab specific
for the K
b-OVA complex [10]. As a control, the irrelevant peptide
SIYRYYGL was used.
Adoptive transfer, immunization and analysis of T cell
response
10
6 (unless otherwise stated) LN CD8
+ T cells from female
Vb5LTAOCa
2/2 or OT-I (CD45.2
+) mice were injected i.v. into
female B6.SJL (CD45.1
+) hosts. 2 days later, mice were
immunized i.v. with 5610
5 male B6.SJL mature peptide-pulsed
DCs. At different days post- immunization, brachial or inguinal
LNs were removed surgically and sequentially to follow response
in the same mouse. Effector functions and response in tertiary sites
were analyzed as described previously [9].
Quantitative analysis of gene expression
Total RNA was isolated from sorted CD8
+CD45.2
+ cells at day
4 post-immunization and reverse transcribed into cDNA. Real-
time PCRs were performed using SYBR Green (Invitrogen) on an
Applied Biosystems 7500 real Time PCR system. The primer
sequences used are listed in Table S1. The DCT value (relative
expression) for each sample was determined by calculating the
difference between the CT value of the target and the CT value of
the endogenous reference gene (HPRT).
Time-lapse microscopy
Poly L Lysine-treated coverslips were treated 1 h with
fibronectin type III (Sigma-Aldrich). 2610
5 DCs were then added
and incubated in CO2 independent medium (Invitrogen) at 37uC
into an imaging chamber. 2610
5 OT-1 T cells were added and
sequential differential interference contrast images were recorded
every 10 s over 1 h beginning one min after the addition of T cells
on a Zeiss Z.1 inverted fluorescence microscope with CCD
camera using the Northeclipse aplication from Empix Imaging.
Statistical analysis
Statistics were done using Student’s t or Mann-Whitney tests.
Supporting Information
Figure S1 Phenotype of DCs loaded O/N or 3 h with the
SIINFEKL peptide. (A) The bar chart shows the expression of
CD86, MHC class I (Kb) and II (I-Ab) on LPS matured DCs
loaded O/N (black bar) or 3 h (white bar) with SIINFEKL or on
the surface immature DCs that were not loaded with antigen
(dashed bar). (B) The bar chart shows the amount of IL-12
produced by LPS matured DCs loaded O/N (black bar) or 3 h
(white bar) with SIINFEKL.
Found at: doi:10.1371/journal.pone.0013740.s001 (0.19 MB
TIF)
Figure S2 Generation of effector and memory CD8+ T cells
after immunization with DCs expressing different amount of
MHC-peptide complexes. DCs loaded O/N or for 3 h with the
SIINFEKL peptide were used to immunize mice that have been
adoptively transferred with OVA-specific naı ¨ve CD8+ T cells. T
cell response was evaluated in the same mouse by surgical removal
of LNs. As a negative control, mice were immunized with DCs
loaded with an irrelevant peptide (DC IRR). The percentage and
number of OVA-specific CD8+ T cells (CD45.2+) in one LN are
indicated in each dot plot. One representative experiment out of
10 is shown.
Found at: doi:10.1371/journal.pone.0013740.s002 (7.76 MB TIF)
Figure S3 Number of OVA-specific CD8+ T cells in tertiary
sites. The bar charts show the number of OVA-specific T cells
(CD8+CD45.2+) recovered in the different sites at d4 (A) or d75
(B) post-immunization with DCs loaded O/N (black bar) or 3 h
(white bar) with the SIINFEKL peptide. (C) The relative number
of OVA-specific CD8+ Tm cells recovered from the spleen at day
60 post-imunization with DC O/N (black bar) or DC 3 h (white
bar) is shown.
Found at: doi:10.1371/journal.pone.0013740.s003 (12.15 MB
TIF)
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generated with different Ag doses. (A) Acquisition of a central
memory phenotype by Ag-specific CD8+ T cells. Dot plots show
CD62L/CD44 expression by OVA-specific CD8+ Tm cells 45d
post-immunization with DCs expressing low (DCs 3 h) or high
(DCs O/N) level of Ag while the overlay shows CD127 expression.
(B–C) Similar phenotype of effectors. (B) The overlays show
expression of activation markers, cytokine receptors, migration
marker and memory marker by OVA-specific CD8 T cells 4 d
post-immunization with DCs loaded with low (DCs 3 h) or high
(DCs O/N) level of Ag. Representative of 6 independent
experiments with 2–3 mice per group. (C) To normalize between
experiments, the data are presented as a ratio of MFI of the
CD8+CD45.2+ T cells (SIINFEKL-specific effectors) over the
MFI of CD8+CD45.2- T cells (endogenous population). Each dot
represents a mouse.
Found at: doi:10.1371/journal.pone.0013740.s004 (0.40 MB
TIF)
Figure S5 Epitope density does not affect the clonal burst size of
OVA-specific CD8+ T cells when a low frequency of naı ¨ve T cell
precursors is adoptively transferred. 104 CD8+ (CD45.2+) T cells
from OT-1 mice were transferred into B6.SJL hosts (CD45.1+).
Two days later, mice were immunized with 5 X 105 mature DCs
loaded overnight (DC O/N) or 3 hours (DC 3 h) with the
SIINFEKL peptide. On days 4, 6 and 7 after immunization,
responsive CD8+ T cells were detected in blood, lymph node (LN)
and spleen by staining with anti-CD45.2 and anti-CD8 Abs.
Found at: doi:10.1371/journal.pone.0013740.s005 (3.86 MB
TIF)
Figure S6 Effector functions are not affected by the amount of
Ag seen at priming. (A) The percentage of specific lysis is shown
for effectors obtained after immunization with DC pulsed with
SIINFEKL O/N (DC O/N) or 3 h (DC 3 h). CFSE-labeled
splenocytes pulsed or not with SIINFEKL were injected at d4
post-immunization. After 4 h, the presence of target cells was
analyzed in the spleen. (B) The overlays show perforin (left) and
granzyme B (right) staining for OVA-specific CD8+ T cells
(CD8+CD45.2+, thick line) and recipient naı ¨ve T cells
(CD8+CD45.2-, thin line) at d4 post-immunization. (C) The
graph shows the MFI of perforin and granzyme B stainings at the
peak of response. Each dot represents one mouse. (D) The
histograms show IL-2 (left), TNF-alpha (middle) and IFN-gamma
(right) production by OVA-specific CD8+ T cells (CD8+CD45.2+,
thick line) and recipient T cells (CD8+CD45.2-, thin line) at d4
post-immunization. (E) Quantification of the amount of IL-2,
TNF-alpha and IFN-gamma produced by the two groups of
effectors. The MFI of cytokine production by effector CD8+ T
cells was normalized to the MFI of the recipient CD8+ T cells.
Results from panel A to E are from 2 independent experiments
with 3 mice per group.
Found at: doi:10.1371/journal.pone.0013740.s006 (0.37 MB
TIF)
Figure S7 The level of antigenic presentation to naı ¨ve CD8+ T
cells does not affect effector T cell survival. (A) Similar expression
of Bcl-2 in effectors. The overlay represents Bcl-2 expression at the
peak of response (d4) in CD8+CD45.2+ T cells obtained after
immunization with DCs loaded O/N (DC O/N) or 3 h (DC 3 h).
Dashed line, endogenous population (CD8+CD45.2-); dotted line,
isotype control. (B) Kinetic of Bcl-2 expression. Bcl-2 expression is
shown over time for effector CD8+ T cells generated after
immunization with DCs loaded O/N (DC O/N) or 3 h (DC 3 h)
with the OVA peptide. The MFI of Bcl-2 expression by effector
CD8+ T cells was normalized to the MFI of the recipient CD8+ T
cells. 2 independent experiments with 3 mice per group. (C)
Expression of pro- and anti-apoptic molecules by effector CD8+ T
cells. Effectors were sorted from spleen and LNs at d4 post-
immunization to perform qPCR. The relative expression of the
different genes after immunization with DC O/N or with DC 3 h
is shown (normalized to HPRT). 3 independent experiments with
3 mice per group.
Found at: doi:10.1371/journal.pone.0013740.s007 (4.31 MB
TIF)
Table S1
Found at: doi:10.1371/journal.pone.0013740.s008 (0.04 MB
DOC)
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